In ‘Global Arms Race’ for COVID Vaccine, Patents are Key Incentive

Patent may not be an option for vaccine, U.S. government could overtake patent

Despite the partial reopening of cities across the country, the novel coronavirus is still spreading. As of April 29, the national death toll surpassed 60,000. And as virus-related deaths continue to rise, governments around the world are calling for a cure. The search to find a vaccine to fight the virus has created a “new global arms race,” according to the National Law Review — and this race isn’t just for the cure but for the patents. Obtaining a patent for a COVID-19 vaccine poses some challenges before even reaching the patent office, according to Justin Krieger, Denver office m

We hope you’ve enjoyed your free articles. Don’t miss another story. Subscribe today or login to read the rest of this content

Previous articleLegal Lasso: Colorado Cuts Prison Populations
Next articleLegal Lasso: Polis to Meet With Trump Regarding Economic Aid

LEAVE A REPLY

Please enter your comment!
Please enter your name here